Apr 11, 2024 | Laboratory UTCBS, Research
The Biotherapy team, in collaboration with the Nanobiosciences and microsystems team of unit 8640 of the CNRS (P.A.S.T.E.U.R) of the Ecole Normale Supérieure, has just published an article in the Journal of the American Chemical Society on the intracellular...
Feb 22, 2024 | Laboratory UTCBS, Research
A disease is considered rare when it affects less than 1 in 2,000 people. There are around 7,000 such diseases, affecting 3 million people in France. But most of these diseases are still shrouded in secrecy: the cause of more than half of them is unknown, which...
Feb 7, 2024 | Laboratory UTCBS, Research
#Towards widespread access to messenger RNA (mRNA) vaccines! A licensing agreement between SATT Aquitaine and Nexbiome Therapeutics has been signed to exploit an innovative technology developed by a team from the I2M research laboratory (University of Bordeaux, CNRS,...
Dec 6, 2023 | Laboratory UTCBS, Research
At the SFNano congress in Montpellier, Pauline Chavrier, a second-year PhD student, wins the best poster award for her work on Evaluation of functionalized liposomes’ targeting efficiency by assessing in vitro uptake and in vivo biodistribution. Evaluation of...
Nov 9, 2023 | Laboratory UTCBS, Research
Here is Shanghai’s thematic ranking for “Pharmaceuticals and Pharmaceutical Sciences”. Shanghai Ranking. UPCité is ranked 3rd just behind Harvard and University College. More information on the Université Paris Cité website Global Ranking of Acad....
Nov 3, 2023 | Laboratory UTCBS, Research
Invited for this month′s cover, the researchers from UTCBS and CiTCoM from Université Paris Cité (Paris, France), as well as Materia Nova (Mons, Belgium). The image emphasizes the deep eutectic solvent preparation thanks to hydrogen bond acceptor and donor...
